🇰🇷 South Korea Country × Condition
covid 19 Clinical Trials in South Korea
Active clinical trials for covid 19 with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT06159283 Phase 2
Recruiting
Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment
Enrollment
58 pts
Country
🇰🇷 South Korea
Jaehoon Ko
View Trial → NCT05890612
Recruiting
A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19
Enrollment
3,000 pts
Country
🇰🇷 South Korea
Pfizer
View Trial → Frequently Asked Questions
How many covid 19 clinical trials are active in South Korea?
There are currently 2 active clinical trials for covid 19 with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a covid 19 clinical trial in South Korea?
To join a covid 19 clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are covid 19 trials in South Korea?
Active covid 19 trials in South Korea span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.